These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24501945)

  • 1. [Mebeverina drugs in the treatment of functional disorders of the digestive system].
    Butov MA; Shurpo EM; Kuznetsov EM; Shelukhina SV
    Eksp Klin Gastroenterol; 2013; (5):36-41. PubMed ID: 24501945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of the efficacy of mebeverine in the complex therapy of chronic noncalculolis cholecystitis and biliary dysfunction].
    Maev IV; Samsonov AA; Ul'iankina EV; Nikushkina IN; Salova LM; Shakh IuS
    Eksp Klin Gastroenterol; 2007; (2):120-5. PubMed ID: 17539356
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon].
    Secco GB; Di Somma C; Arnulfo G; Ricci C
    Minerva Med; 1983 Mar; 74(13):699-702. PubMed ID: 6339996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern approaches to the therapy of biliary system diseases].
    Galiullin AR; Khakamova GA; Uliamaeva VV; Latypova GA; Gur'ev DA; Volevach LV
    Eksp Klin Gastroenterol; 2010; (4):109-13. PubMed ID: 20623959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of biliary dysfunction in the pathogenesis of gallstone disease].
    Il'chenko IA; Deliukina OV
    Eksp Klin Gastroenterol; 2011; (7):70-8. PubMed ID: 22364003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effectiveness of spasmolytic therapy in chronic acalculous cholecystitis].
    Shaĭkhutdinova OV; Galiakberova AR; Gur'ev DA; Ionova SI; Volevach LV
    Eksp Klin Gastroenterol; 2009; (2):115-8. PubMed ID: 19552029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of irritable bowel syndrome. Two doses of mebeverine compared.
    Prout BJ
    Practitioner; 1983 Oct; 227(1384):1607-8. PubMed ID: 6356119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mebeverine for complex treatment of opisthorchiasis].
    Stepanova TF; Stepanova KB; Chirko IuV; Masterskikh AIu
    Eksp Klin Gastroenterol; 2006; (6):61-4. PubMed ID: 17615648
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program "odyssey".
    Maev IV; Kucheravy YA; Tsukanov VV; Eremnia EY; Andreev DN; Abdulhakov SR; Akhmedov VA; Batskov SS; Vasyutin AV; V'yuchnova ES; Ivanchenko DN; Luzina EV; Krapivnaya OV; Onuchina EV; Osipenko MF; Simanenkov VI; Tonkih YL; Khomeriki NM; Shklyaev AE; Akimov AV; Sokolov KA
    Ter Arkh; 2018 Aug; 90(8):40-47. PubMed ID: 30701938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of etmosin on biliary motility disorders in patients with ischemic heart disease].
    Lyzohub VH; Pliskevych DA; Nikoliuk LS; Zaval's'ka TV
    Lik Sprava; 2004; (5-6):77-9. PubMed ID: 15605830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of duspatalin therapy in the treatment and prevention of post-cholecystectomy syndrome].
    Lipnitskiĭ EM; Isakova OV; Movchun VA; Apdatskaia MD
    Vestn Ross Akad Med Nauk; 2011; (1):7-11. PubMed ID: 21395089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional condition of the hepatobiliary system in patients with biliary dyskinesia].
    Vakhrushev IaM; Penkina IA
    Ter Arkh; 2007; 79(2):41-4. PubMed ID: 17460967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Duspatalin in functional disorders of the Oddi's sphincter in patients subjected cholecystectomy].
    Il'chenko AA; Bystrovskaia EV
    Eksp Klin Gastroenterol; 2002; (4):21-2, 130. PubMed ID: 12503268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of duspatalin in the treatment and prophylaxis of postcholecystectomic syndrome].
    Lipnitskiĭ EM; Isakova OV; Dzhadzhanidze AD; Ardatskaia MD
    Eksp Klin Gastroenterol; 2008; (3):86-93. PubMed ID: 19145887
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome.
    Gilbody JS; Fletcher CP; Hughes IW; Kidman SP
    Int J Clin Pract; 2000 Sep; 54(7):461-4. PubMed ID: 11070572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled study of the effects of tiropramide on biliary dyskinesia.
    Trabucchi E; Baratti C; Centemero A; Zuin M; Rizzitelli E; Colombo R
    Pharmatherapeutica; 1986; 4(9):541-50. PubMed ID: 2429334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials of a new antispasmodic agent in digestive system diseases].
    Picq ; Consigny
    Bord Med; 1970 Mar; 3(3):861-5. PubMed ID: 5463584
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on papillary function and effect of prifinium bromide and other antispasmodics on motility of the papillary region (sphincter of Oddi) in humans.
    Kobayashi K; Mitani E; Tatsumi S; Sasaki Y; Nakamura M; Yamada H
    Clin Ther; 1985; 7(2):154-63. PubMed ID: 2859116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The therapeutic value of anabolic steroids in gastroenterology].
    Demole M
    Schweiz Med Wochenschr; 1966 Mar; 96(9):291-6. PubMed ID: 5983996
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of no-shpa and phenicaberan in hypertonic biliary dyskinesia in patients with viral hepatitis].
    Andreĭchin MA; Kiĭko LG; Il'ina NI; Gnatovich IG
    Vrach Delo; 1988 Nov; (11):100-1. PubMed ID: 3238957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.